Comments
Loading...
Cartesian Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RNAC | Benzinga
Cartesian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-0.830
Quarterly Revenue Estimate
$100.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$38.91M
Analyze the earnings history of Cartesian Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics | -$10.50 | -$0.82 | — | — | $5.84M | $1.00M | — | — | 05/07/2025 | Get Alert |
| RNAC | Cartesian Therapeutics | -$41.70 | -$0.83 | — | — | $8.27M | $100.00K | — | — | 04/08/2025 | Get Alert |
| RNAC | Cartesian Therapeutics | -$1.80 | -$0.73 | -$1.13 | -54.79% | $6.55M | $2.54M | $387.00K | -84.76% | 11/07/2024 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.07 | -$1.19 | $0.54 | 145.38% | $5.25M | $1.83M | $33.45M | 1727.60% | 08/08/2024 | Get Alert |
| RNAC | Cartesian Therapeutics | -$4.24 | -$0.88 | -$10.50 | -1093.18% | $5.94M | $1.25M | $5.84M | 367.20% | 05/08/2024 | Get Alert |
| RNAC | Cartesian Therapeutics | $0.04 | -$0.90 | -$41.70 | -4533.33% | $16.80M | $5.87M | $8.27M | 40.82% | 03/07/2024 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.05 | -$1.80 | -$1.80 | 0.00% | $20.71M | $11.02M | $6.55M | -40.55% | 11/13/2023 | Get Alert |
| RNAC | Cartesian Therapeutics | $0.06 | -$0.08 | -$0.07 | 12.50% | $39.27M | $11.09M | $5.25M | -52.67% | 08/17/2023 | Get Alert |
| RNAC | Cartesian Therapeutics | $0.08 | -$0.09 | -$0.14 | -55.56% | $34.00M | $11.83M | $5.94M | -49.81% | 05/04/2023 | Get Alert |
| RNAC | Cartesian Therapeutics | $0.03 | -$0.07 | $0.04 | 157.14% | $29.94M | $11.68M | $16.80M | 43.79% | 03/02/2023 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.16 | -$0.01 | -$0.05 | -400.00% | $24.43M | $25.21M | $20.71M | -17.85% | 11/03/2022 | Get Alert |
| RNAC | Cartesian Therapeutics | $0.00 | -$0.09 | $0.06 | 166.67% | $19.66M | — | $39.27M | — | 08/04/2022 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.22 | -$0.11 | $0.08 | 172.73% | $11.05M | $13.12M | $34.00M | 159.14% | 05/05/2022 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.14 | -$0.07 | $0.03 | 142.86% | $11.95M | $17.58M | $29.94M | 70.29% | 03/10/2022 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.09 | -$0.07 | -$0.16 | -128.57% | $4.65M | $12.19M | $24.43M | 100.39% | 11/09/2021 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.25 | -$0.12 | $0.00 | 100.00% | $0.00 | $6.24M | $19.66M | 215.11% | 08/12/2021 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.21 | -$0.12 | -$0.22 | -83.33% | $0.00 | $7.52M | $11.05M | 46.94% | 05/13/2021 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.28 | -$0.12 | -$0.14 | -16.67% | $6.65M | $6.37M | $11.95M | 87.61% | 03/11/2021 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.26 | — | -$0.09 | — | $0.00 | — | $4.65M | — | 11/05/2020 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.37 | -$0.01 | -$0.25 | -2400.00% | $13.00K | $18.75M | $0.00 | -100.00% | 08/06/2020 | Get Alert |
| RNAC | Cartesian Therapeutics | -$0.31 | -$0.28 | -$0.21 | 25.00% | $10.00K | — | $0.00 | — | 05/07/2020 | Get Alert |
Cartesian Therapeutics (RNAC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-1.13 | $-0.73 | -54.8 % |
| Q2 | 2024-08-08 | $0.54 | $-1.19 | 145.4 % |
| Q1 | 2024-05-08 | $-10.50 | $-0.88 | -1093.2 % |
| Q4 | 2024-03-07 | $-41.70 | $-0.90 | -4533.3 % |
Cartesian Therapeutics (RNAC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $387.00K | $2.54M | -84.8 % |
| Q2 | 2024-08-08 | $33.45M | $1.83M | 1727.6 % |
| Q1 | 2024-05-08 | $5.84M | $1.25M | 367.2 % |
| Q4 | 2024-03-07 | $8.27M | $5.87M | 40.8 % |
FAQ
When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?
Cartesian Therapeutics (RNAC) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Cartesian Therapeutics (NASDAQ:RNAC)?
The Actual EPS was $-1.13, which missed the estimate of $-0.73.
What were Cartesian Therapeutics’s (NASDAQ:RNAC) revenues?
The Actual Revenue was $387K, which missed the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.